“Severe Hyponatremia with Normokalemia in Pembrolizumab-Lenvatinib Combination Therapy for Metastatic Renal Cell Carcinoma: A Case of Suspected Secondary Adrenal Insufficiency and Clinical Differentials” (2025) Open Access Indonesian Journal of Medical Reviews, 6(1), pp. 35–50. doi:10.37275/oaijmr.v6i1.826.